N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine

C90H101Cl4N19O9S3 — CID 161317631

IUPACN-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine
SMILESCN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCNCC3)n2c1)S(C)(=O)=O.COCC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(N(C)S(C)(=O)=O)cn23)CC1.O=C(c1cscn1)N1CCN(Cc2c(-c3ccc(Cl)cc3Cl)nc3cnc(C4CC4)cn23)CC1.c1ccc(-c2ccc3nc(C4CCOCC4)c(CN4CCOCC4)n3c2)cc1
InChIInChI=1S/C24H22Cl2N6OS.C23H28ClN5O4S.C23H27N3O2.C20H24ClN5O2S/c25-16-3-4-17(18(26)9-16)23-21(32-11-19(15-1-2-15)27-10-22(32)29-23)12-30-5-7-31(8-6-30)24(33)20-13-34-14-28-20;1-26(34(3,31)32)19-8-9-21-25-23(17-4-6-18(24)7-5-17)20(29(21)14-19)15-27-10-12-28(13-11-27)22(30)16-33-2;1-2-4-18(5-3-1)20-6-7-22-24-23(19-8-12-27-13-9-19)21(26(22)16-20)17-25-10-14-28-15-11-25;1-24(29(2,27)28)17-7-8-19-23-20(15-3-5-16(21)6-4-15)18(26(19)13-17)14-25-11-9-22-10-12-25/h3-4,9-11,13-15H,1-2,5-8,12H2;4-9,14H,10-13,15-16H2,1-3H3;1-7,16,19H,8-15,17H2;3-8,13,22H,9-12,14H2,1-2H3
InChIKeyVJSBJQVPFNBTHK-UHFFFAOYSA-N
MW1830.93 g/mol
LogP13.52
Rot. Bonds21

About N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine

N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine (PubChem CID 161317631) has the molecular formula C90H101Cl4N19O9S3 and a molecular weight of 1830.93 g/mol. Its IUPAC name is N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine.

Molecular Properties

Compound NameN-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine
PubChem CID161317631
Molecular FormulaC90H101Cl4N19O9S3
Molecular Weight1830.93 g/mol
Exact Mass1827.59
IUPAC NameN-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine
SMILESCN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCNCC3)n2c1)S(C)(=O)=O.COCC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(N(C)S(C)(=O)=O)cn23)CC1.O=C(c1cscn1)N1CCN(Cc2c(-c3ccc(Cl)cc3Cl)nc3cnc(C4CC4)cn23)CC1.c1ccc(-c2ccc3nc(C4CCOCC4)c(CN4CCOCC4)n3c2)cc1
InChIInChI=1S/C24H22Cl2N6OS.C23H28ClN5O4S.C23H27N3O2.C20H24ClN5O2S/c25-16-3-4-17(18(26)9-16)23-21(32-11-19(15-1-2-15)27-10-22(32)29-23)12-30-5-7-31(8-6-30)24(33)20-13-34-14-28-20;1-26(34(3,31)32)19-8-9-21-25-23(17-4-6-18(24)7-5-17)20(29(21)14-19)15-27-10-12-28(13-11-27)22(30)16-33-2;1-2-4-18(5-3-1)20-6-7-22-24-23(19-8-12-27-13-9-19)21(26(22)16-20)17-25-10-14-28-15-11-25;1-24(29(2,27)28)17-7-8-19-23-20(15-3-5-16(21)6-4-15)18(26(19)13-17)14-25-11-9-22-10-12-25/h3-4,9-11,13-15H,1-2,5-8,12H2;4-9,14H,10-13,15-16H2,1-3H3;1-7,16,19H,8-15,17H2;3-8,13,22H,9-12,14H2,1-2H3
InChIKeyVJSBJQVPFNBTHK-UHFFFAOYSA-N
XLogP13.52
TPSA263.04 Ų
H-Bond Donors1
H-Bond Acceptors25
Rotatable Bonds21
Heavy Atoms125
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001830.93
LogP ≤ 513.52
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1025

Analyze N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine?
The IUPAC name of N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine (CID 161317631) is N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine.
What is the SMILES notation for N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine?
The canonical SMILES for N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine is CN(c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCNCC3)n2c1)S(C)(=O)=O.COCC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(N(C)S(C)(=O)=O)cn23)CC1.O=C(c1cscn1)N1CCN(Cc2c(-c3ccc(Cl)cc3Cl)nc3cnc(C4CC4)cn23)CC1.c1ccc(-c2ccc3nc(C4CCOCC4)c(CN4CCOCC4)n3c2)cc1.
What is the InChIKey of N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine?
The InChIKey is VJSBJQVPFNBTHK-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H22Cl2N6OS.C23H28ClN5O4S.C23H27N3O2.C20H24ClN5O2S/c25-16-3-4-17(18(26)9-16)23-21(32-11-19(15-1-2-15)27-10-22(32)29-23)12-30-5-7-31(8-6-30)24(33)20-13-34-14-28-20;1-26(34(3,31)32)19-8-9-21-25-23(17-4-6-18(24)7-5-17)20(29(21)14-19)15-27-10-12-28(13-11-27)22(30)16-33-2;1-2-4-18(5-3-1)20-6-7-22-24-23(19-8-12-27-13-9-19)21(26(22)16-20)17-25-10-14-28-15-11-25;1-24(29(2,27)28)17-7-8-19-23-20(15-3-5-16(21)6-4-15)18(26(19)13-17)14-25-11-9-22-10-12-25/h3-4,9-11,13-15H,1-2,5-8,12H2;4-9,14H,10-13,15-16H2,1-3H3;1-7,16,19H,8-15,17H2;3-8,13,22H,9-12,14H2,1-2H3.
What are the key properties of N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine?
N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine has a molecular weight of 1830.93 g/mol, XLogP of 13.52, 21 rotatable bonds, 1 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;N-[2-(4-chlorophenyl)-3-(piperazin-1-ylmethyl)imidazo[1,2-a]pyridin-6-yl]-N-methylmethanesulfonamide;[4-[[6-cyclopropyl-2-(2,4-dichlorophenyl)imidazo[1,2-a]pyrazin-3-yl]methyl]piperazin-1-yl]-(1,3-thiazol-4-yl)methanone;4-[[2-(oxan-4-yl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine is sourced from PubChem (CID 161317631), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).